FULGENT GENETICS, INC. Accumulated Other Comprehensive Income
FULGENT GENETICS, INC. (FLGT) had Accumulated Other Comprehensive Income of $1.92 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-30
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.92M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $4.54M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $7.51M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $6.82M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $1.92M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $4.54M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $7.51M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $6.82M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $6.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $4.33M 10-Q · filed 2025-05-02 |
| 2024-12-31 | -$368.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $9.18M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$877.00K 10-Q · filed 2024-08-02 |
| 2024-03-31 | -$1.10M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $1.21M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$16.89M 10-Q · filed 2023-11-03 |
| 2023-06-30 | -$20.75M 10-Q · filed 2023-08-04 |
| 2023-03-31 | -$17.20M 10-Q · filed 2023-05-05 |
| 2022-12-31 | -$20.90M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$25.60M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$22.42M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$12.49M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$759.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | -$212.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$265.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | -$216.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $438.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $607.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.05M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$193.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $146.00K 10-K · filed 2021-03-08 |
| 2019-09-30 | $179.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $203.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $95.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$35.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | -$57.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | -$82.00K 10-Q · filed 2018-08-13 |
| 2018-03-31 | -$87.00K 10-Q · filed 2018-05-14 |
| 2017-12-31 | -$44.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $10.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$68.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$85.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$103.00K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |